• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of oenvmedOccupational and Environmental MedicineCurrent TOCInstructions for authors
Occup Environ Med. Jul 1998; 55(7): 446–452.
PMCID: PMC1757616

Measurement of vitamin D3 metabolites in smelter workers exposed to lead and cadmium

Abstract

OBJECTIVES: To investigate the effects of lead and cadmium on the metabolic pathway of vitamin D3. METHODS: Blood and urinary cadmium and urinary total proteins were measured in 59 smelter workers occupationally exposed to lead and cadmium. In 19 of these workers, the plasma vitamin D3 metabolites, (25-hydroxycholecalciferol (25 OHD3), 24R, 25-dihydroxycholecalciferol (24R,25(OH)2D3) and 1 alpha,25- dihydroxycholecalciferol (1 alpha, 25(OH)2D3)) were measured together with blood lead. Vitamin D3 metabolites were measured by radioimmunoassay, (RIA), lead and cadmium by atomic absorption spectrophotometry, and total proteins with a test kit. RESULTS: Ranges for plasma 25(OH)D3, 24R,25(OH)2D3 and 1 alpha,25(OH)2D3 were 1.0-51.9 ng/ml, 0.6-5.8 ng/ml, and 0.1-75.7 pg/ml, respectively. Ranges for blood lead were 1-3.7 mumol/l, (21-76 micrograms/dl), blood cadmium 6- 145 nmol/l, and urinary cadmium 3-161 nmol/l. Total proteins in random urine samples were 2.1-32.6 mg/dl. Concentrations of lead and cadmium in blood showed no correlation (correlation coefficient -0.265) but there was a highly significant correlation between blood and urinary cadmium. Concentrations for 24R,25(OH)2D3 were depressed below the normal range as blood and urinary cadmium increased, irrespective of lead concentrations. High cadmium concentrations were associated with decreased plasma 1 alpha,25(OH)2D3 when lead concentrations were < 1.9 mumol/l and with above normal plasma 1 alpha,25(OH)2D3 when lead concentrations were > 1.9 mumol/l, Kruskal-Wallis analysis of variance (K-W ANOVA) chi 2 = 10.3, p = 0.006. Plasma 25(OH)D3 was negatively correlated with both urinary total proteins and urinary cadmium, but showed no correlation with plasma 24R,25(OH)2D3, 1 alpha,25(OH)2D3, blood lead, or blood cadmium. CONCLUSION: Continuous long term exposure to cadmium may result in a state of equilibrium between blood and urinary cadmium. Cadmium concentrations in blood could be predicted from the cadmium concentration of the urine, (regression coefficient +0.35 SE 0.077). Exposure to cadmium alone decreased the concentrations of 1 alpha,25(OH)2D3 and 24R,25(OH)2D3, whereas exposure to both cadmium and lead increased the concentrations of 1 alpha,25(OH)2D3. It has been suggested that cadmium and lead interact with renal mitochondrial hydroxylases of the vitamin D3 endocrine complex. Perturbation of the vitamin D metabolic pathway by cadmium may result in health effect, such as osteoporosis or osteomalacia, risks which are possibly increased in the presence of lead.

 

Full Text

The Full Text of this article is available as a PDF (187K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Lockitch G. Perspectives on lead toxicity. Clin Biochem. 1993 Oct;26(5):371–381. [PubMed]
  • Tandon SK, Khandelwal S, Jain VK, Mathur N. Influence of dietary iron deficiency on acute metal intoxication. Biometals. 1993 Summer;6(2):133–138. [PubMed]
  • Barry PS, Mossman DB. Lead concentrations in human tissues. Br J Ind Med. 1970 Oct;27(4):339–351. [PMC free article] [PubMed]
  • Hicks DG, O'Keefe RJ, Reynolds KJ, Cory-Slechta DA, Puzas JE, Judkins A, Rosier RN. Effects of lead on growth plate chondrocyte phenotype. Toxicol Appl Pharmacol. 1996 Sep;140(1):164–172. [PubMed]
  • Börjesson J, Mattsson S, Strömberg U, Gerhardsson L, Schütz A, Skerfving S. Lead in fingerbone: a tool for retrospective exposure assessment. Arch Environ Health. 1997 Mar-Apr;52(2):104–112. [PubMed]
  • Kjellström T. Mechanism and epidemiology of bone effects of cadmium. IARC Sci Publ. 1992;(118):301–310. [PubMed]
  • Roels H, Bernard AM, Cárdenas A, Buchet JP, Lauwerys RR, Hotter G, Ramis I, Mutti A, Franchini I, Bundschuh I, et al. Markers of early renal changes induced by industrial pollutants. III. Application to workers exposed to cadmium. Br J Ind Med. 1993 Jan;50(1):37–48. [PMC free article] [PubMed]
  • Kido T, Honda R, Yamada Y, Tsuritani I, Ishizaki M, Nogawa K. alpha 1-Microglobulin determination in urine for the early detection of renal tubular dysfunctions caused by exposure to cadmium. Toxicol Lett. 1985 Feb-Mar;24(2-3):195–201. [PubMed]
  • Holick MF. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol. 1981 Jul;77(1):51–58. [PubMed]
  • Takeuchi A, Okano T, Kobayashi T. The existence of 25-hydroxyvitamin D3-1 alpha-hydroxylase in the liver of carp and bastard halibut. Life Sci. 1991;48(3):275–282. [PubMed]
  • Fraser DR, Kodicek E. Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature. 1970 Nov 21;228(5273):764–766. [PubMed]
  • Burgos-Trinidad M, DeLuca HF. Kinetic properties of 25-hydroxyvitamin D- and 1,25-dihydroxyvitamin D-24-hydroxylase from chick kidney. Biochim Biophys Acta. 1991 Jun 24;1078(2):226–230. [PubMed]
  • Gray RW, Ghazarian JG. Solubilization and reconstitution of kidney 25-hydroxyvitamin D3 1 alpha- and 24-hydroxylases from vitamin D-replete pigs. Biochem J. 1989 Apr 15;259(2):561–568. [PMC free article] [PubMed]
  • Mandel ML, Moorthy B, Swartz SJ, Garancis JC, Ghazarian JG. Monoclonal antibodies to chick renal calcium regulating hemeproteins. Biochemical and immunohistochemical interactions with mitochondrial 25-hydroxyvitamin D3 hydroxylases. J Clin Lab Immunol. 1990 Jan;31(1):1–10. [PubMed]
  • Rubin LP, Yeung B, Vouros P, Vilner LM, Reddy GS. Evidence for human placental synthesis of 24,25-dihydroxyvitamin D3 and 23,25-dihydroxyvitamin D3. Pediatr Res. 1993 Jul;34(1):98–104. [PubMed]
  • Bikle DD, Halloran BP, Riviere JE. Production of 1,25 dihydroxyvitamin D3 by perfused pig skin. J Invest Dermatol. 1994 May;102(5):796–798. [PubMed]
  • Guilhou JJ, Colette C, Monpoint S, Lancrenon E, Guillot B, Monnier L. Vitamin D metabolism in psoriasis before and after phototherapy. Acta Derm Venereol. 1990;70(4):351–354. [PubMed]
  • Wasserman RH, Brindak ME, Buddle MM, Cai Q, Davis FC, Fullmer CS, Gilmour RF, Jr, Hu C, Mykkanen HM, Tapper DN. Recent studies on the biological actions of vitamin D on intestinal transport and the electrophysiology of peripheral nerve and cardiac muscle. Prog Clin Biol Res. 1990;332:99–126. [PubMed]
  • Fuss M, Pepersack T, Gillet C, Karmali R, Corvilain J. Calcium and vitamin D metabolism in granulomatous diseases. Clin Rheumatol. 1992 Mar;11(1):28–36. [PubMed]
  • Miyaura C, Suda T. [Vitamin D]. Nihon Rinsho. 1993 Apr;51(4):893–900. [PubMed]
  • Rubinger D, Krause I, Alkoby-Gibbs M, Popovtzer MM. 24,25(OH)2D3 affects the calcemic effects of 1,25(OH)2D3 by mechanisms independent of intestinal calcium absorption. Bone Miner. 1991 Dec;15(3):219–226. [PubMed]
  • Matsumoto T, Yamato H, Okazaki R, Kumegawa M, Ogata E. Effect of 24,25-dihydroxyvitamin D3 in osteoclasts. Proc Soc Exp Biol Med. 1992 Jun;200(2):161–164. [PubMed]
  • Yamato H, Okazaki R, Ishii T, Ogata E, Sato T, Kumegawa M, Akaogi K, Taniguchi N, Matsumoto T. Effect of 24R,25-dihydroxyvitamin D3 on the formation and function of osteoclastic cells. Calcif Tissue Int. 1993 Mar;52(3):255–260. [PubMed]
  • Grosse B, Bourdeau A, Lieberherr M. Oscillations in inositol 1,4,5-trisphosphate and diacyglycerol induced by vitamin D3 metabolites in confluent mouse osteoblasts. J Bone Miner Res. 1993 Sep;8(9):1059–1069. [PubMed]
  • Fullmer CS, Rosen JF. Effect of dietary calcium and lead status on intestinal calcium absorption. Environ Res. 1990 Feb;51(1):91–99. [PubMed]
  • Long GJ, Rosen JF, Pounds JG. Lead impairs the production of osteocalcin by rat osteosarcoma (ROS 17/2.8) cells. Toxicol Appl Pharmacol. 1990 Nov;106(2):270–277. [PubMed]
  • Pounds JG, Long GJ, Rosen JF. Cellular and molecular toxicity of lead in bone. Environ Health Perspect. 1991 Feb;91:17–32. [PMC free article] [PubMed]
  • Fullmer CS, Edelstein S, Wasserman RH. Lead-binding properties of intestinal calcium-binding proteins. J Biol Chem. 1985 Jun 10;260(11):6816–6819. [PubMed]
  • Rosen JF, Chesney RW, Hamstra A, DeLuca HF, Mahaffey KR. Reduction in 1,25-dihydroxyvitamin D in children with increased lead absorption. N Engl J Med. 1980 May 15;302(20):1128–1131. [PubMed]
  • Yoshiki S, Yanagisawa T, Kimura M, Otaki N, Suzuki M. Bone and kidney lesions in experimental cadmium intoxication. Arch Environ Health. 1975 Nov;30(11):559–562. [PubMed]
  • Kazantzis G, Armstrong BG. Renal function in relation to low levels of cadmium exposure in a group of smelter workers. Environ Health Perspect. 1984 Mar;54:193–199. [PMC free article] [PubMed]
  • Kazantzis G, Lam TH, Sullivan KR. Mortality of cadmium-exposed workers. A five-year update. Scand J Work Environ Health. 1988 Aug;14(4):220–223. [PubMed]
  • Lidor C, Sagiv P, Amdur B, Gepstein R, Otremski I, Hallel T, Edelstein S. Decrease in bone levels of 1,25-dihydroxyvitamin D in women with subcapital fracture of the femur. Calcif Tissue Int. 1993 Feb;52(2):146–148. [PubMed]
  • Edelstein S, Charman M, Lawson DE, Kodicek E. Competitive protein-binding assay for 25-hydroxycholecalciferol. Clin Sci Mol Med. 1974 Feb;46(2):231–240. [PubMed]
  • Macart M, Gerbaut L. An improvement of the Coomassie Blue dye binding method allowing an equal sensitivity to various proteins: application to cerebrospinal fluid. Clin Chim Acta. 1982 Jun 16;122(1):93–101. [PubMed]
  • Macart M, Gerbaut L. Evaluation of an improved Coomassie dye binding method for urinary protein assay. Clin Chim Acta. 1984 Aug 15;141(1):77–84. [PubMed]
  • Rosen JF, Chesney RW. Circulating calcitriol concentrations in health and disease. J Pediatr. 1983 Jul;103(1):1–17. [PubMed]
  • Brody DJ, Pirkle JL, Kramer RA, Flegal KM, Matte TD, Gunter EW, Paschal DC. Blood lead levels in the US population. Phase 1 of the Third National Health and Nutrition Examination Survey (NHANES III, 1988 to 1991) JAMA. 1994 Jul 27;272(4):277–283. [PubMed]
  • Staessen J, Lauwerys R. Health effects of environmental exposure to cadmium in a population study. J Hum Hypertens. 1993 Apr;7(2):195–199. [PubMed]
  • Mahaffey KR, Rosen JF, Chesney RW, Peeler JT, Smith CM, DeLuca HF. Association between age, blood lead concentration, and serum 1,25-dihydroxycholecalciferol levels in children. Am J Clin Nutr. 1982 Jun;35(6):1327–1331. [PubMed]
  • Ghazarian JG. The renal mitochondrial hydroxylases of the vitamin D3 endocrine complex: how are they regulated at the molecular level? J Bone Miner Res. 1990 Sep;5(9):897–903. [PubMed]
  • Long GJ, Pounds JG, Rosen JF. Lead intoxication alters basal and parathyroid hormone-regulated cellular calcium homeostasis in rat osteosarcoma (ROS 17/2.8) cells. Calcif Tissue Int. 1992 May;50(5):451–458. [PubMed]
  • Katsuta O, Hiratsuka H, Matsumoto J, Iwata H, Toyota N, Tsuchitani M, Umemura T, Marumo F. Cadmium-induced osteomalacic and osteopetrotic lesions in ovariectomized rats. Toxicol Appl Pharmacol. 1994 May;126(1):58–68. [PubMed]
  • Gur E, Waner T, Barushka-Eizik O, Oron U. Effect of cadmium on bone repair in young rats. J Toxicol Environ Health. 1995 Jul;45(3):249–260. [PubMed]
  • Nolan CV, Shaikh ZA. Lead nephrotoxicity and associated disorders: biochemical mechanisms. Toxicology. 1992;73(2):127–146. [PubMed]
  • Walton JR. Intranuclear inclusions in the lead-poisoned cultured kidney cell. J Pathol. 1974 Apr;112(4):213–215. [PubMed]
  • Goyer RA. Transplacental transport of lead. Environ Health Perspect. 1990 Nov;89:101–105. [PMC free article] [PubMed]
  • Ehle AL, McKee DC. Neuropsychological effect of lead in occupationally exposed workers: a critical review. Crit Rev Toxicol. 1990;20(4):237–255. [PubMed]
  • Saha H. Calcium and vitamin D homeostasis in patients with heavy proteinuria. Clin Nephrol. 1994 May;41(5):290–296. [PubMed]
  • Navarro JA, Granadillo VA, Salgado O, Rodríguez-Iturbe B, García R, Delling G, Romero RA. Bone metal content in patients with chronic renal failure. Clin Chim Acta. 1992 Oct 30;211(3):133–142. [PubMed]
  • Nogawa K, Tsuritani I, Kido T, Honda R, Ishizaki M, Yamada Y. Serum vitamin D metabolites in cadmium-exposed persons with renal damage. Int Arch Occup Environ Health. 1990;62(3):189–193. [PubMed]

Articles from Occupational and Environmental Medicine are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...